Journal article
Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in mice.
- Abstract:
-
The development of a chlamydial vaccine that elicits protective mucosal immunity is of paramount importance in combatting the global spread of sexually transmitted Chlamydia trachomatis (Ct) infections. While the identification and prioritization of chlamydial antigens is a crucial prerequisite for efficacious vaccine design, it is likely that novel adjuvant development and selection will also play a pivotal role in the translational potential of preclinical Ct vaccines. Although the molecula...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 1.2MB)
-
- Publisher copy:
- 10.1016/j.vaccine.2016.06.081
Authors
Funding
Bill and Melinda Gates Foundation
More from this funder
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Vaccine Journal website
- Volume:
- 34
- Issue:
- 35
- Pages:
- 4123-4131
- Publication date:
- 2016-07-04
- Acceptance date:
- 2016-06-29
- DOI:
- EISSN:
-
1873-2518
- ISSN:
-
0264-410X
- Pmid:
-
27389169
- Source identifiers:
-
718079
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:718079
- UUID:
-
uuid:c7fd328c-4006-4b3e-87a4-9c2d3e889df5
- Local pid:
- pubs:718079
- Deposit date:
- 2018-01-30
Terms of use
- Copyright holder:
- Crown Copyright
- Copyright date:
- 2016
- Notes:
- Crown Copyright © 2016 Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record